Holen Sie sich die Stockscreener-App
1.19
10.19%
0.11
Handel nachbörslich:
1.19
Schlusskurs vom Vortag:
$1.08
Offen:
$1.06
24-Stunden-Volumen:
702.32K
Relative Volume:
3.29
Marktkapitalisierung:
$79.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-126.61M
KGV:
-0.5721
EPS:
-2.08
Netto-Cashflow:
$-60.14M
1W Leistung:
+2.59%
1M Leistung:
-11.85%
6M Leistung:
-54.92%
1J Leistung:
-30.00%
1-Tages-Spanne:
$1.06
$1.21
1-Wochen-Bereich:
$0.75
$1.22
52-Wochen-Spanne:
$0.75
$4.65
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Vergleichen Sie GBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
1.19 | 79.48M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-19 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-24 | Eingeleitet | William Blair | Outperform |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-07 | Eingeleitet | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Next-Generation Biomanufacturing Market Vendor and Technology Assessment Report 2024-2031 - openPR
MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio - BioSpace
Generation Bio stock hits 52-week low at $1.11 - Investing.com
Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles By Investing.com - Investing.com South Africa
Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles - Investing.com Australia
BB Biotech AG Reduces Stake in Generation Bio Co: An In-Depth Analysis - GuruFocus.com
Molecular Diagnostics Market to grow by USD 7.92 Billion (2024-2028), driven by rising age-related diseases; Report highlights AI-driven transformationTechnavio - Lelezard
US Penny Stocks Spotlight: LiveOne And 2 Other Promising Picks - Simply Wall St
Baker BROS. Advisors LP Acquires 737,988 Shares of Generation Bio Co. (NASDAQ:GBIO) - MarketBeat
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Generation Bio Co. Reports Q3 2024 Financials and Progress - TipRanks
Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN
SK Bioscience's SKYCellflu Recognized as Next-generation World-class Product - BusinessKorea
Generation Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdles - Investing.com Australia
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections - Business Wire
Next Generation Gene pioneers gene therapy approach with China data - BioWorld Online
FY2024 EPS Estimates for Generation Bio Boosted by Analyst - MarketBeat
Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Landlord’s alleged breach doesn’t justify end of rent payments - Massachusetts Lawyers Weekly
Generation Bio Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance UK
Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028 - Chicago Star Media
Generation Bio earnings beat by $0.04, revenue topped estimates - Investing.com
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results - The Manila Times
Generation Bio : Reports Recent Business Highlights and Third Quarter 2024 Financial Results Form 8 K - Marketscreener.com
Generation Bio Reports Breakthrough T-Cell Delivery, Slashes Q3 Losses by 46% | GBIO Stock News - StockTitan
CrossBridge Bio Secures $10 Million Financing to Advance the Development of Next-Generation Dual-Payload ADC Therapies - BioSpace
Promising Penny Stocks On US Exchanges In November 2024 - Simply Wall St
Researchers Seek to Unlock the Secrets to Human Longevity - Securities.io
Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock - Yahoo Finance
ST Launches AI-enhanced Bio-Sensing Chip for Next-gen Wearables - EE Times India
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 13.4% in October - MarketBeat
Layoff Tracker: Marinus Cuts Employees After Disappointing Phase III Trial - BioSpace
Generation Bio (NASDAQ:GBIO) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT - The Bakersfield Californian
Generation Bio Announces the Presentation of Preclinical - GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - StockTitan
Cubist Systematic Strategies LLC Has $54,000 Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 6.1% in September - MarketBeat
Viral And Non-Viral Vector Manufacturing Market Report 2024-2033 | Size, Trends, Outlook - WhaTech
Alnylam’s founder brings in a $135M series A for City Therapeutics - BioWorld Online
City Therapeutics: $135 Million (Series A) Raised For RNAi-Based Medicine - Pulse 2.0
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine - BioSpace
Renaissance Technologies LLC Sells 28,100 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio's SWOT analysis: innovative dna tech propels stock potential - Investing.com India
Generation Bio Co. (NASDAQ:GBIO) Sees Large Increase in Short Interest - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in September - Defense World
Rhumbline Advisers Buys 5,430 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Generation Bio Co-Aktie (GBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Paone Antoinette | CHIEF OPERATING OFFICER |
Jul 01 '24 |
Sale |
2.74 |
6,719 |
18,410 |
13,807 |
| Paone Antoinette | CHIEF OPERATING OFFICER |
Jan 02 '24 |
Sale |
1.62 |
2,445 |
3,961 |
5,828 |
| Samayoa Phillip | CHIEF STRATEGY OFFICER |
Jan 02 '24 |
Sale |
1.62 |
2,445 |
3,961 |
107,256 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):